US3654090A
(en)
|
1968-09-24 |
1972-04-04 |
Organon |
Method for the determination of antigens and antibodies
|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
US4016043A
(en)
|
1975-09-04 |
1977-04-05 |
Akzona Incorporated |
Enzymatic immunological method for the determination of antigens and antibodies
|
US4265823A
(en)
|
1979-01-04 |
1981-05-05 |
Robert E. Kosinski |
Aurothiosteroids
|
US4737462A
(en)
|
1982-10-19 |
1988-04-12 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
|
US4518584A
(en)
|
1983-04-15 |
1985-05-21 |
Cetus Corporation |
Human recombinant interleukin-2 muteins
|
JPS60174629A
(ja)
|
1984-02-20 |
1985-09-07 |
Mitsubishi Monsanto Chem Co |
二軸延伸されたポリアミドフイルムの製造方法
|
US4699880A
(en)
|
1984-09-25 |
1987-10-13 |
Immunomedics, Inc. |
Method of producing monoclonal anti-idiotype antibody
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US4704692A
(en)
|
1986-09-02 |
1987-11-03 |
Ladner Robert C |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・2・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
US5284931A
(en)
|
1987-05-04 |
1994-02-08 |
Dana Farber Cancer Institute |
Intercellular adhesion molecules, and their binding ligands
|
US4935234A
(en)
|
1987-06-11 |
1990-06-19 |
Dana-Farber Cancer Institute |
Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
|
US5219997A
(en)
|
1987-07-06 |
1993-06-15 |
Dana-Farber Cancer Institute |
Monoclonal antibody which inhibits the adhesion functions of the β integrin, CR3
|
US5114842A
(en)
|
1987-07-08 |
1992-05-19 |
The Scripps Research Institute |
Peptides and antibodies that inhibit platelet adhesion
|
US4925572A
(en)
|
1987-10-20 |
1990-05-15 |
Pall Corporation |
Device and method for depletion of the leukocyte content of blood and blood components
|
US4880548A
(en)
|
1988-02-17 |
1989-11-14 |
Pall Corporation |
Device and method for separating leucocytes from platelet concentrate
|
US5147637A
(en)
|
1988-06-07 |
1992-09-15 |
The Rockefeller University |
Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5235049A
(en)
|
1989-01-24 |
1993-08-10 |
Molecular Therapeutics, Inc. |
Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1
|
US5002873A
(en)
|
1989-03-17 |
1991-03-26 |
Fred Hutchinson Cancer Research Center |
DNA sequence encoding a lymphocyte adhesion receptor for high endothelium
|
US5091302A
(en)
|
1989-04-27 |
1992-02-25 |
The Blood Center Of Southeastern Wisconsin, Inc. |
Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof
|
US5272263A
(en)
|
1989-04-28 |
1993-12-21 |
Biogen, Inc. |
DNA sequences encoding vascular cell adhesion molecules (VCAMS)
|
US5137806A
(en)
|
1989-12-11 |
1992-08-11 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the detection of sequences in selected DNA molecules
|
US5264554A
(en)
|
1990-01-19 |
1993-11-23 |
The Blood Center Of Southeastern Wisconsin, Inc. |
Platelet cell adhesion molecule and variants thereof
|
GB9009548D0
(en)
|
1990-04-27 |
1990-06-20 |
Celltech Ltd |
Chimeric antibody and method
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
US5210015A
(en)
|
1990-08-06 |
1993-05-11 |
Hoffman-La Roche Inc. |
Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
|
WO1992002819A2
(en)
|
1990-08-10 |
1992-02-20 |
The Regents Of The University Of California |
Assay for ulcerative colitis and primary sclerosing cholangitis
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
EP0546073B1
(en)
|
1990-08-29 |
1997-09-10 |
GenPharm International, Inc. |
production and use of transgenic non-human animals capable of producing heterologous antibodies
|
US5085318A
(en)
|
1990-11-19 |
1992-02-04 |
Leverick Kathy L |
Secured disc folder
|
US6277969B1
(en)
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
CA2110387A1
(en)
|
1991-06-11 |
1992-12-23 |
Antonin R. Defougerolles |
Intercellular adhesion molecule-3 and its binding ligands
|
LU91067I2
(fr)
|
1991-06-14 |
2004-04-02 |
Genentech Inc |
Trastuzumab et ses variantes et dérivés immuno chimiques y compris les immotoxines
|
US5227369A
(en)
|
1991-07-11 |
1993-07-13 |
The Regents Of The University Of California |
Compositions and methods for inhibiting leukocyte adhesion to cns myelin
|
US5234810A
(en)
|
1991-09-20 |
1993-08-10 |
The United States Of America As Represented By The Secretary Of Agriculture |
Diagnostic assays for genetic mutations associated with bovine leukocyte adhesion deficiency
|
WO1993007485A1
(en)
|
1991-10-10 |
1993-04-15 |
The Regents Of The University Of California |
Rare immunoglobulin framework regions associated with human disease
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
GB9126918D0
(en)
|
1991-12-19 |
1992-02-19 |
Univ London |
Members of specific binding pairs;methods of their making and using
|
US5236081A
(en)
|
1992-01-31 |
1993-08-17 |
Shape Inc. |
Compact disc package
|
EP0656789B1
(en)
|
1992-08-21 |
1997-12-17 |
Genentech, Inc. |
Method for treating a lfa-1-mediated disorder
|
US5263743A
(en)
|
1992-09-25 |
1993-11-23 |
Pharmagraphics, Inc. |
Package label
|
EP0695189B1
(en)
|
1992-12-29 |
1998-11-25 |
Genentech, Inc. |
Treatment of inflammatory bowel disease with ifn-gamma inhibitors
|
US5830675A
(en)
|
1993-03-10 |
1998-11-03 |
Cedars-Sinai Medical Center |
Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis
|
DK0615129T3
(da)
|
1993-03-10 |
2000-08-07 |
Cedars Sinai Medical Center |
Fremgangsmåder til selektiv påvisning af perinukleært anti-neutrophilt cytoplasmatisk antistof fra ulcerativ colitis eller
|
GB9307503D0
(en)
|
1993-04-13 |
1993-06-02 |
Kodak Ltd |
Method of making a photographic developer solution
|
GB9325182D0
(en)
|
1993-12-08 |
1994-02-09 |
T Cell Sciences Inc |
Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions
|
US5681699A
(en)
|
1994-02-11 |
1997-10-28 |
Cedars-Sinai Medical Center |
Methods of diagnosing ulcerative colitis and Crohn's disease
|
ATE207967T1
(de)
|
1994-05-17 |
2001-11-15 |
Cedars Sinai Medical Center |
Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen
|
US5494920A
(en)
|
1994-08-22 |
1996-02-27 |
Eli Lilly And Company |
Methods of inhibiting viral replication
|
US5491063A
(en)
|
1994-09-01 |
1996-02-13 |
Hoffmann-La Roche Inc. |
Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
|
US5691151A
(en)
|
1994-10-07 |
1997-11-25 |
Regents Of University Of California |
Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
|
US6824767B2
(en)
|
1994-11-07 |
2004-11-30 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
US20030198640A1
(en)
|
1994-11-07 |
2003-10-23 |
Human Genome Sciences, Inc. |
Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta
|
WO1996014328A1
(en)
|
1994-11-07 |
1996-05-17 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
WO2000066608A1
(en)
|
1999-04-30 |
2000-11-09 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
US20030129189A1
(en)
|
1994-11-07 |
2003-07-10 |
Guo-Liang Yu |
Tumor necrosis factor-gamma
|
US7820798B2
(en)
|
1994-11-07 |
2010-10-26 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
US6599719B2
(en)
|
1994-11-07 |
2003-07-29 |
Human Genome Sciences, Inc. |
Nucleic acid molecules encoding tumor necrosis factor-gamma-alpha
|
US7597886B2
(en)
|
1994-11-07 |
2009-10-06 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
JPH08248832A
(ja)
|
1995-03-06 |
1996-09-27 |
Mita Ind Co Ltd |
画像形成装置
|
US5518488A
(en)
|
1995-03-20 |
1996-05-21 |
Schluger; Allen |
CD holder of cardboard and method of construction
|
US5607879A
(en)
|
1995-06-28 |
1997-03-04 |
Taiwan Semiconductor Manufacturing Company Ltd. |
Method for forming buried plug contacts on semiconductor integrated circuits
|
ES2176484T3
(es)
|
1995-08-18 |
2002-12-01 |
Morphosys Ag |
Bancos de proteinas/(poli)peptidos.
|
US6706484B1
(en)
|
1995-08-18 |
2004-03-16 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
US6632976B1
(en)
|
1995-08-29 |
2003-10-14 |
Kirin Beer Kabushiki Kaisha |
Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
|
US5840300A
(en)
|
1995-09-11 |
1998-11-24 |
Trustees Of The University Of Pennsylvania |
Methods and compositions comprising single chain recombinant antibodies
|
US5942390A
(en)
|
1996-01-12 |
1999-08-24 |
Cedars-Sinai Medical Center |
Method of diagnosing predisposition for ulcerative colitis in Jewish population by detection of interleukin-1 receptor antagonist polymorphism
|
US6713061B1
(en)
|
1996-03-12 |
2004-03-30 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US7357927B2
(en)
*
|
1996-03-12 |
2008-04-15 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US5590769A
(en)
|
1996-03-20 |
1997-01-07 |
Lin; Shi-Ping |
Individual CD case
|
EP0938320B2
(en)
|
1996-03-26 |
2014-06-18 |
Michael S. Kopreski |
Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer
|
US6025539A
(en)
|
1996-04-09 |
2000-02-15 |
Mayo Foundation For Medical Education And Research |
IL-5 transgenic mouse
|
WO1997038642A1
(en)
|
1996-04-12 |
1997-10-23 |
Cedars-Sinai Medical Center |
Methods of determining the risk of pouchitis development
|
US6074835A
(en)
|
1996-04-12 |
2000-06-13 |
Regents Of The Univ. Of California |
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone H1
|
US5874233A
(en)
|
1996-04-12 |
1999-02-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitis
|
US5916748A
(en)
|
1996-04-12 |
1999-06-29 |
Cedars-Sinai Medical Center |
Method of diagnosing a clinical subtype of crohn's disease with features of ulcerative colitis
|
US5683698A
(en)
|
1996-08-02 |
1997-11-04 |
New England Deaconess Hospital |
Formulation for alleviating symptoms associated with arthritis
|
JPH1078528A
(ja)
|
1996-09-03 |
1998-03-24 |
Fujitsu Ltd |
光合分波器及び波長分割多重モジュール
|
US6034102A
(en)
|
1996-11-15 |
2000-03-07 |
Pfizer Inc |
Atherosclerosis treatment
|
US6114395A
(en)
|
1996-11-15 |
2000-09-05 |
Pfizer Inc. |
Method of treating atherosclerosis
|
US7514232B2
(en)
|
1996-12-06 |
2009-04-07 |
Becton, Dickinson And Company |
Method for detecting T cell response to specific antigens in whole blood
|
BR9806954A
(pt)
|
1997-01-14 |
2000-03-21 |
Human Genome Sciences Inc |
Receptores 6a e 6b do fator de necrose tumoral
|
US7285267B2
(en)
|
1997-01-14 |
2007-10-23 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptors 6α & 6β
|
US20040013664A1
(en)
|
1997-01-14 |
2004-01-22 |
Gentz Reiner L. |
Tumor necrosis factor receptors 6 alpha & 6 beta
|
US6197928B1
(en)
|
1997-03-14 |
2001-03-06 |
The Regents Of The University Of California |
Fluorescent protein sensors for detection of analytes
|
US5968741A
(en)
|
1997-04-11 |
1999-10-19 |
Cedars-Sinai Medical Center |
Methods of diagnosing a medically resistant clinical subtype of ulcerative colitis
|
US6183951B1
(en)
|
1997-04-11 |
2001-02-06 |
Prometheus Laboratories, Inc. |
Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-Th1 cytokine therapy
|
US20030129215A1
(en)
|
1998-09-24 |
2003-07-10 |
T-Ram, Inc. |
Medical devices containing rapamycin analogs
|
IL136544A0
(en)
|
1997-12-05 |
2001-06-14 |
Scripps Research Inst |
Humanization of murine antibody
|
US6297367B1
(en)
|
1997-12-30 |
2001-10-02 |
Chiron Corporation |
Polynucleotide encoding TNFL1
|
US20020006613A1
(en)
|
1998-01-20 |
2002-01-17 |
Shyjan Andrew W. |
Methods and compositions for the identification and assessment of cancer therapies
|
US6607879B1
(en)
|
1998-02-09 |
2003-08-19 |
Incyte Corporation |
Compositions for the detection of blood cell and immunological response gene expression
|
JP2002508940A
(ja)
|
1998-03-13 |
2002-03-26 |
デイナ−ファーバー キャンサー インスティチュート,インコーポレイテッド |
ヒト化抗体およびその使用
|
US5947281A
(en)
|
1998-07-06 |
1999-09-07 |
Kaneff; Mitchell S. |
Unfolding disc holder
|
US20050123938A1
(en)
|
1999-01-06 |
2005-06-09 |
Chondrogene Limited |
Method for the detection of osteoarthritis related gene transcripts in blood
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
US7368527B2
(en)
|
1999-03-12 |
2008-05-06 |
Human Genome Sciences, Inc. |
HADDE71 polypeptides
|
CA2267481A1
(en)
|
1999-03-30 |
2000-09-30 |
Gabriel Pulido-Cejudo |
Critical interdependency: from the role of estrogen on breast cancer to the susceptibility of women towards hiv infection
|
US6539374B2
(en)
|
1999-06-03 |
2003-03-25 |
Microsoft Corporation |
Methods, apparatus and data structures for providing a uniform representation of various types of information
|
CA2377414A1
(en)
|
1999-06-15 |
2000-12-21 |
John D. Potter |
Nutrient formulations for disease reduction, and related treatment and component screening methods
|
US6692916B2
(en)
|
1999-06-28 |
2004-02-17 |
Source Precision Medicine, Inc. |
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
|
CA2339889C
(en)
|
1999-07-02 |
2012-01-31 |
Morphosys Ag |
Identification of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
|
US20030204075A9
(en)
|
1999-08-09 |
2003-10-30 |
The Snp Consortium |
Identification and mapping of single nucleotide polymorphisms in the human genome
|
US6376176B1
(en)
|
1999-09-13 |
2002-04-23 |
Cedars-Sinai Medical Center |
Methods of using a major histocompatibility complex class III haplotype to diagnose Crohn's disease
|
US6762042B2
(en)
|
1999-12-09 |
2004-07-13 |
Merck & Co., Inc. |
DNA molecules encoding human NHL a DNA helicase
|
EP1276899A2
(en)
|
1999-12-10 |
2003-01-22 |
Whitehead Institute For Biomedical Research |
Ibd-related polymorphisms
|
US6869762B1
(en)
|
1999-12-10 |
2005-03-22 |
Whitehead Institute For Biomedical Research |
Crohn's disease-related polymorphisms
|
US20020165137A1
(en)
|
2000-01-31 |
2002-11-07 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
CA2395872A1
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
AU2001245371A1
(en)
|
2000-02-28 |
2001-09-12 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
|
US6348316B1
(en)
|
2000-04-12 |
2002-02-19 |
Cedars-Sinai Medical Center |
Genetic testing for determining the risk of pouchitis development
|
US20110131679A2
(en)
|
2000-04-19 |
2011-06-02 |
Thomas La Rosa |
Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
|
AU5984701A
(en)
|
2000-05-12 |
2001-11-20 |
Univ Oregon Health & Science |
Method of treating immune pathologies with low dose estrogen
|
US6972187B2
(en)
|
2000-05-12 |
2005-12-06 |
Millennium Pharmaceuticals, Inc. |
OAT5 molecules and uses therefor
|
US7138237B1
(en)
|
2000-05-19 |
2006-11-21 |
Cedars-Sinai Medical Center |
Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
|
US6571638B2
(en)
|
2000-06-30 |
2003-06-03 |
Sawtek, Inc. |
Surface-acoustic-wave pressure sensor and associated methods
|
AU2001277857A1
(en)
|
2000-07-07 |
2002-01-21 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
DE60121346T8
(de)
|
2000-08-04 |
2007-12-13 |
Ludwig Institute For Cancer Research |
Suppressor-Gen
|
US20020019837A1
(en)
|
2000-08-11 |
2002-02-14 |
Balnaves James A. |
Method for annotating statistics onto hypertext documents
|
US6824989B1
(en)
|
2000-09-01 |
2004-11-30 |
Upstate Biotechnology, Inc. |
Recombinant monoclonal antibody to phosphotyrosine-containing proteins
|
US6812339B1
(en)
|
2000-09-08 |
2004-11-02 |
Applera Corporation |
Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
|
US20070037165A1
(en)
|
2000-09-08 |
2007-02-15 |
Applera Corporation |
Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
|
US20020048566A1
(en)
|
2000-09-14 |
2002-04-25 |
El-Deiry Wafik S. |
Modulation of cellular apoptosis and methods for treating cancer
|
AU2126502A
(en)
|
2000-10-03 |
2002-04-15 |
Gene Logic, Inc. |
Gene expression profiles in granulocytic cells
|
JP3898126B2
(ja)
|
2000-10-24 |
2007-03-28 |
俊一 塩澤 |
慢性関節リウマチに関与するゲノム、その診断方法、その発症可能性の判定方法、それらの検出用診断キットおよび、慢性関節リウマチの治療方法ならびに治療薬剤
|
USH2191H1
(en)
|
2000-10-24 |
2007-06-05 |
Snp Consortium |
Identification and mapping of single nucleotide polymorphisms in the human genome
|
CA2427471C
(en)
|
2000-10-30 |
2010-12-21 |
The Regents Of The University Of Michigan |
Nod2 nucleic acids and proteins
|
US7820447B2
(en)
|
2000-12-22 |
2010-10-26 |
Sagres Discovery Inc. |
Compositions and methods for cancer
|
US7892730B2
(en)
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
US20040072154A1
(en)
|
2000-12-22 |
2004-04-15 |
Morris David W. |
Novel compositions and methods for cancer
|
US20030092019A1
(en)
|
2001-01-09 |
2003-05-15 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
|
WO2003008583A2
(en)
|
2001-03-02 |
2003-01-30 |
Sagres Discovery |
Novel compositions and methods for cancer
|
US20020182274A1
(en)
|
2001-03-21 |
2002-12-05 |
Kung-Ming Lu |
Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
|
US20050143333A1
(en)
|
2001-05-18 |
2005-06-30 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
|
US20050182007A1
(en)
|
2001-05-18 |
2005-08-18 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
|
US20050261219A1
(en)
|
2001-05-18 |
2005-11-24 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
CA2391711A1
(en)
|
2001-06-26 |
2002-12-26 |
University Of Guelph |
Non-radioactive assay of lipopolysaccharide kinases
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
CA2460621A1
(en)
|
2001-09-19 |
2003-03-27 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
GB0124315D0
(en)
|
2001-10-10 |
2001-11-28 |
Oxagen Ltd |
Inflammatory bowel disease
|
KR20040064275A
(ko)
|
2001-11-09 |
2004-07-16 |
소스 프리시전 메디슨, 인코포레이티드 |
유전자 발현 프로파일을 이용한 질병의 동정, 모니터링,치료 및 생물학적 상태의 확인
|
US7767390B2
(en)
|
2001-11-20 |
2010-08-03 |
Oncomedx, Inc. |
Methods for evaluating drug-resistance gene expression in the cancer patient
|
US7871619B2
(en)
|
2001-11-30 |
2011-01-18 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
US20070237770A1
(en)
|
2001-11-30 |
2007-10-11 |
Albert Lai |
Novel compositions and methods in cancer
|
EP2224012B1
(en)
|
2001-12-17 |
2013-01-30 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
FI20020078A
(fi)
|
2002-01-15 |
2003-07-16 |
Danisco |
Immuunijärjestelmän stimulointi polydextroosilla
|
US6878518B2
(en)
|
2002-01-22 |
2005-04-12 |
The Trustees Of The University Of Pennsylvania |
Methods for determining steroid responsiveness
|
US20070015271A1
(en)
|
2002-04-04 |
2007-01-18 |
Rosen Craig A |
Human secreted proteins
|
US7745180B2
(en)
|
2002-04-24 |
2010-06-29 |
Hitachi Chemical Co., Ltd. |
Device and method for high-throughput quantification of mRNA from whole blood
|
US7238717B2
(en)
|
2002-05-24 |
2007-07-03 |
Millennium Pharmaceuticals, Inc. |
CCR9 inhibitors and methods of use thereof
|
EP1507548B1
(en)
|
2002-05-27 |
2014-10-01 |
CanImGuide Therapeutics AB |
Method for determining immune system affecting compounds
|
US20040053263A1
(en)
|
2002-08-30 |
2004-03-18 |
Abreu Maria T. |
Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
|
TW200409759A
(en)
|
2002-09-25 |
2004-06-16 |
Wyeth Corp |
Substituted 4-(indazol-3-yl)phenols
|
DE60336406D1
(de)
|
2002-10-16 |
2011-04-28 |
Purdue Pharma Lp |
Antikörper, die an zellassoziiertes ca 125/0722p binden, und verfahren zu deren anwendung
|
JP2006517916A
(ja)
|
2002-10-30 |
2006-08-03 |
ザ シービーアール インスティテュート フォー バイオメディカル リサーチ インコーポレーティッド |
Rna干渉物質を用いてアポトーシス関連疾患を治療および予防する方法
|
WO2004048600A2
(en)
|
2002-11-22 |
2004-06-10 |
Emory University |
Diagnostic tests and methods for diagnosing inflammatory bowel disease
|
EP1567555A4
(en)
|
2002-11-27 |
2006-06-21 |
Biogen Idec Inc |
HUMANIZED ANTIBODIES AGAINST CHEMOTOXIC MONOCYTE PROTEINS
|
CA2506672C
(en)
|
2002-12-23 |
2012-04-17 |
Schering Corporation |
Il-23 for treating cutaneous wounds
|
AU2002953533A0
(en)
|
2002-12-24 |
2003-01-16 |
Arthron Limited |
Fc receptor modulating compounds and compositions
|
US20070020637A1
(en)
|
2003-01-21 |
2007-01-25 |
Research Association For Biotechnology |
Full-length cDNA
|
US8071304B2
(en)
|
2003-04-05 |
2011-12-06 |
The Johns Hopkins University |
Methods for detecting a polymorphism in the NFKB1 gene promoter
|
US7662569B2
(en)
|
2003-04-11 |
2010-02-16 |
Cedars-Sinai Medical Center |
Methods of assessing Crohn's disease patient phenotype by I2 serologic response
|
EP1642135A1
(en)
|
2003-06-06 |
2006-04-05 |
AstraZeneca AB |
Method for diagnosing inflammatory bowel disease
|
DK1667730T3
(da)
|
2003-08-20 |
2013-09-23 |
Univ Miami |
Sammensætninger og fremgangsmåder til behandling af inflammatorisk lungesygdom
|
WO2005018436A2
(en)
|
2003-08-26 |
2005-03-03 |
The Trustees Of Boston University |
Methods for the diagnosis, prognosis and treatment of metabolic syndrome
|
WO2005030133A2
(en)
|
2003-09-22 |
2005-04-07 |
Yale University |
Treatment with agonists of toll-like receptors
|
US20070161003A1
(en)
|
2003-09-29 |
2007-07-12 |
Morris David W |
Novel therapeutic targets in cancer
|
US20050101889A1
(en)
|
2003-11-06 |
2005-05-12 |
Freeman Gary A. |
Using chest velocity to process physiological signals to remove chest compression artifacts
|
US20070054278A1
(en)
|
2003-11-18 |
2007-03-08 |
Applera Corporation |
Polymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof
|
CA2546837A1
(en)
|
2003-12-03 |
2005-06-16 |
Glycominds Ltd. |
Method for diagnosing diseases based on levels of anti-glycan antibodies
|
KR20070052694A
(ko)
|
2004-01-09 |
2007-05-22 |
더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 |
유전자 발현을 위한 세포-유형-특이적 패턴
|
AU2005206389A1
(en)
|
2004-01-27 |
2005-08-04 |
Compugen Ltd. |
Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
|
AU2005249360B2
(en)
|
2004-04-12 |
2011-07-21 |
Medimmune, Llc |
Anti-IL-9 antibody formulations and uses thereof
|
EP1763790A1
(fr)
|
2004-04-19 |
2007-03-21 |
Kartoo SA |
Procede et dispositif de recherche avec conservation personnalisee des resultats
|
US20060154276A1
(en)
|
2004-05-13 |
2006-07-13 |
Prometheus Laboratories Inc. |
Methods of diagnosing inflammatory bowel disease
|
US7759079B2
(en)
|
2004-05-13 |
2010-07-20 |
Prometheus Laboratories Inc. |
Methods of diagnosing inflammatory bowel disease
|
US7407753B2
(en)
|
2004-05-24 |
2008-08-05 |
Yissum Research Development Company Of The Hebrewuniversityofjerusalem |
Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis
|
WO2005115115A2
(en)
|
2004-05-25 |
2005-12-08 |
Hitachi Chemical Co., Ltd. |
Method of measuring cancer susceptibility
|
AU2005271892A1
(en)
|
2004-07-10 |
2006-02-16 |
Alexion Pharmaceuticals, Inc. |
Methods for discovering antibodies specific to cancer cells and antibodies discovered thereby
|
WO2006020430A2
(en)
|
2004-08-12 |
2006-02-23 |
Genentech, Inc. |
Novel composition and methods for the treatment of immune related disease
|
TWI380996B
(zh)
|
2004-09-17 |
2013-01-01 |
Hoffmann La Roche |
抗ox40l抗體
|
AR051444A1
(es)
|
2004-09-24 |
2007-01-17 |
Centocor Inc |
Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
|
WO2006045318A2
(en)
|
2004-10-27 |
2006-05-04 |
Aarhus Universitet |
Diagnosis and treatment of immune-related diseases
|
JP2008518610A
(ja)
|
2004-11-03 |
2008-06-05 |
アルマック ダイアグノスティックス リミテッド |
トランスクリプトームマイクロアレイ技法およびそれを使用する方法
|
WO2006063093A2
(en)
|
2004-12-08 |
2006-06-15 |
Cedars-Sinai Medical Center |
Methods for diagnosis and treatment of crohn's disease
|
WO2010048415A1
(en)
|
2008-10-22 |
2010-04-29 |
Cedars-Sinai Medical Center |
Methods of using jak3 genetic variants to diagnose and predict crohn's disease
|
WO2006075254A2
(en)
|
2005-01-13 |
2006-07-20 |
Progenika Biopharma, S.A. |
Methods and products for in vitro genotyping
|
US8110347B2
(en)
|
2005-04-15 |
2012-02-07 |
Canimguide Therapeutics Ab |
Diagnostic method for detecting cancer by measuring amount of cytokine like IL-6
|
EP1888089B9
(en)
|
2005-04-28 |
2012-08-08 |
Hitachi Chemical Research Center, Inc. |
Ex vivo gene expression in whole blood as a model of assessment of individual variation to dietary supplements
|
CN102321174B
(zh)
*
|
2005-05-06 |
2013-10-16 |
津莫吉尼蒂克斯公司 |
Il-31单克隆抗体及使用方法
|
CA2607697C
(en)
|
2005-05-10 |
2015-01-06 |
Biogen Idec Ma Inc. |
Treating and evaluating inflammatory disorders
|
ES2301280A1
(es)
|
2005-05-16 |
2008-06-16 |
Fina Biotech S.L.U. |
Metodo para diagnosticar la enfermedad de alzheimer.
|
US20090317388A1
(en)
*
|
2005-05-25 |
2009-12-24 |
Linda Burkly |
Tl1a in treatment of disease
|
CN103172739A
(zh)
|
2005-06-30 |
2013-06-26 |
Abbvie公司 |
Il-12/p40结合蛋白
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
CA2621083C
(en)
|
2005-08-30 |
2017-04-11 |
University Of Miami |
Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins
|
WO2007025989A2
(en)
|
2005-09-02 |
2007-03-08 |
Innogenetics N.V. |
Nucleic acid variants in the toll like receptor genes associated with altered innate immunity
|
WO2007038754A2
(en)
|
2005-09-27 |
2007-04-05 |
Source Mdx |
Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
|
US8234129B2
(en)
|
2005-10-18 |
2012-07-31 |
Wellstat Vaccines, Llc |
Systems and methods for obtaining, storing, processing and utilizing immunologic and other information of individuals and populations
|
US20090258848A1
(en)
|
2005-12-06 |
2009-10-15 |
The Johns Hopkins University |
Biomarkers for inflammatory bowel disease
|
US20070161031A1
(en)
|
2005-12-16 |
2007-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Functional arrays for high throughput characterization of gene expression regulatory elements
|
JP2009528264A
(ja)
|
2006-01-10 |
2009-08-06 |
ザイモジェネティクス,インコーポレイティド |
Il−31アンタゴニストを用いて神経組織における疼痛及び炎症を治療する方法
|
US20100019016A1
(en)
|
2006-03-23 |
2010-01-28 |
Edoga John K |
Vascular Anastomotic Staplers
|
ATE518011T1
(de)
|
2006-04-07 |
2011-08-15 |
Hitachi Chemical Co Ltd |
Erhöhte expression von t- zellenrezeptorvermittelter tumornekrosefaktorsuperfamilie und chemokin-mrna in peripheren blut leukozyten bei patienten mit morbus& xa;crohn
|
US20100041600A1
(en)
|
2006-06-09 |
2010-02-18 |
Russel James A |
Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects
|
SG172698A1
(en)
|
2006-06-12 |
2011-07-28 |
Trubion Pharmaceuticals Inc |
Single-chain multivalent binding proteins with effector function
|
AU2007260787A1
(en)
|
2006-06-13 |
2007-12-21 |
Zymogenetics, Inc |
IL-17 and IL-23 antagonists and methods of using the same
|
CA2658563A1
(en)
|
2006-07-26 |
2008-01-31 |
Genizon Biosciences Inc. |
Crohn disease susceptibility gene
|
US7993832B2
(en)
|
2006-08-14 |
2011-08-09 |
Xdx, Inc. |
Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
|
US20080293582A1
(en)
|
2006-08-30 |
2008-11-27 |
Xilin Li |
Markers and Methods for Assessing and Treating Ulcerative Colitis and Related Disorders Using a 43 Gene Panel
|
WO2008033239A2
(en)
|
2006-09-11 |
2008-03-20 |
Applera |
Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
|
KR20090069318A
(ko)
|
2006-09-25 |
2009-06-30 |
베링거 인겔하임 인터내셔날 게엠베하 |
Cb2 수용체를 조절하는 화합물
|
WO2008048902A2
(en)
|
2006-10-13 |
2008-04-24 |
Cedars-Sinai Medical Center |
Methods of using single nucleotide polymorphisms in the il23r gene to predict or diagnose inflammatory bowel disease
|
US20100267575A1
(en)
|
2006-10-17 |
2010-10-21 |
Childrens Hospital Medical Center |
Gene array technique for predicting response in inflammatory bowel diseases
|
US20100098721A1
(en)
|
2006-10-18 |
2010-04-22 |
St. Jude Children's Reseach Hospital |
Methods and compositions for preparing a universal influenza vaccine
|
WO2008067195A2
(en)
|
2006-11-17 |
2008-06-05 |
Genizon Biosciences Inc. |
Genemap of the human genes associated with crohn's disease
|
US20080131887A1
(en)
|
2006-11-30 |
2008-06-05 |
Stephan Dietrich A |
Genetic Analysis Systems and Methods
|
EP2097538A4
(en)
|
2006-12-07 |
2011-11-30 |
Switchgear Genomics |
TRANSCRIPTION REAGULATION ELEMENTS OF BIOLOGICAL PATHS, TOOLS AND METHODS
|
US20090186034A1
(en)
|
2006-12-19 |
2009-07-23 |
Genetech, Inc. |
Gene expression markers for inflammatory bowel disease
|
US7691980B2
(en)
|
2007-01-09 |
2010-04-06 |
Bio-Rad Laboratories, Inc. |
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
|
US20110217310A1
(en)
|
2007-01-10 |
2011-09-08 |
Siegel Richard M |
Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology
|
US9896511B2
(en)
|
2007-01-10 |
2018-02-20 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies
|
US20100021917A1
(en)
|
2007-02-14 |
2010-01-28 |
Cedars-Sinai Medical Center |
Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease
|
WO2008106451A2
(en)
|
2007-02-26 |
2008-09-04 |
Cedars-Sinai Medical Center |
Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease
|
WO2010039931A2
(en)
|
2008-10-01 |
2010-04-08 |
Cedars-Sinai Medical Center |
Methods of using il17rd and il23-il17 pathway genes to diagnose crohn's disease
|
WO2008106579A2
(en)
|
2007-02-28 |
2008-09-04 |
Cedars-Sinai Medical Center |
The role of il-12, il-23 and il-17 receptors in inflammatory bowel disease
|
US20150337378A1
(en)
|
2007-02-28 |
2015-11-26 |
Cedars-Sinai Medical Center |
Methods of diagnosis and treatment of inflammatory bowel disease
|
WO2008107389A1
(en)
|
2007-03-02 |
2008-09-12 |
Universite De Liege |
A method for determining the genotype at the crohn's disease locus
|
EP2132338A1
(en)
|
2007-03-06 |
2009-12-16 |
Eesti Biokeskus |
A method to determine single nucleotide polymorphisms and mutations in nucleic acid sequence
|
US20100015156A1
(en)
|
2007-03-06 |
2010-01-21 |
Cedars-Sinai Medical Center |
Diagnosis of inflammatory bowel disease in children
|
WO2008112990A2
(en)
|
2007-03-15 |
2008-09-18 |
Cedars-Sinai Medical Center |
Methods of diagnosis and treatment of crohn's disease
|
US8486640B2
(en)
|
2007-03-21 |
2013-07-16 |
Cedars-Sinai Medical Center |
Ileal pouch-anal anastomosis (IPAA) factors in the treatment of inflammatory bowel disease
|
WO2008134569A2
(en)
|
2007-04-26 |
2008-11-06 |
Cedars-Sinai Medical Center |
Diagnosis and treatment of inflammatory bowel disease in the puerto rican population
|
US20100144903A1
(en)
|
2007-05-04 |
2010-06-10 |
Cedars-Sinai Medical Center |
Methods of diagnosis and treatment of crohn's disease
|
US8153443B2
(en)
|
2007-05-10 |
2012-04-10 |
Cedars-Sinai Medical Center |
Characterization of the CBir1 antigenic response for diagnosis and treatment of Crohn's disease
|
US20150376707A1
(en)
|
2007-05-18 |
2015-12-31 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating inflammatory bowel disease
|
US9305137B1
(en)
|
2007-05-18 |
2016-04-05 |
Cedars-Sinai Medical Center |
Methods of identifying the genetic basis of a disease by a combinatorial genomics approach, biological pathway approach, and sequential approach
|
US20150086567A1
(en)
|
2011-03-25 |
2015-03-26 |
Cedars-Sinai Medical Center |
Role of ifng methylation in inflammatory bowel disease
|
EP2068926A4
(en)
|
2007-05-18 |
2012-08-08 |
Medimmune Llc |
IL-9 IN FIBROTIC AND INFLAMMATORY DISEASES
|
WO2011088380A1
(en)
|
2010-01-15 |
2011-07-21 |
Cedars-Sinai Medical Center |
Methods of using fut2 genetic variants to diagnose crohn's disease
|
WO2012135142A1
(en)
|
2011-03-25 |
2012-10-04 |
Cedars-Sinai Medical Center |
Methods of diagnosing ulcerative colitis and crohn's disease
|
WO2011088237A1
(en)
|
2010-01-13 |
2011-07-21 |
Cedars-Sinai Medical Center |
Methods of using znf365 genetic variants to diagnose crohn's disease
|
US20120190698A1
(en)
|
2011-01-25 |
2012-07-26 |
Cedars-Sinai Medical Center |
Methods of predicting thiopurine response
|
JP2010535501A
(ja)
|
2007-08-09 |
2010-11-25 |
ユニバーシティ オブ オタゴ |
チオプリン薬抵抗性およびチオプリン薬不耐性のリスクがある個体を同定する方法
|
EP2215253B1
(en)
|
2007-09-26 |
2016-04-27 |
Navigenics, Inc. |
Method and computer system for correlating genotype to phenotype using population data
|
WO2009052512A2
(en)
|
2007-10-19 |
2009-04-23 |
Cedars-Sinai Medical Center |
Methods of using genetic variants to diagnose and predict inflammatory bowel disease
|
AU2008320987B2
(en)
|
2007-11-13 |
2014-04-17 |
Teva Biopharmaceuticals Usa, Inc. |
Humanized antibodies against TL1A
|
WO2009073628A2
(en)
|
2007-11-30 |
2009-06-11 |
Celera Corporation |
Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
|
CN101469270B
(zh)
|
2007-12-27 |
2012-08-22 |
牛斌 |
工业连续化塑料裂解器
|
US7773519B2
(en)
|
2008-01-10 |
2010-08-10 |
Nuova Systems, Inc. |
Method and system to manage network traffic congestion
|
EP2242762B1
(en)
|
2008-01-18 |
2015-12-16 |
Bio-Rad Laboratories, Inc. |
Enhanced purification of antibodies and antibody fragments by apatite chromatography
|
WO2009105590A2
(en)
|
2008-02-19 |
2009-08-27 |
The Children's Hospital Of Philadelphia |
Identification of pediatric onset inflammatory bowel disease loci and methods of use thereof for the diagnosis and treatment of the same
|
US20090299645A1
(en)
|
2008-03-19 |
2009-12-03 |
Brandon Colby |
Genetic analysis
|
US20110124644A1
(en)
|
2008-05-20 |
2011-05-26 |
Cedars-Sinai Medical Center |
Methods of diagnosing and characterizing cannabinoid signaling in crohn's disease
|
US20110111418A1
(en)
|
2008-06-23 |
2011-05-12 |
Cedars-Sinai Medical Center |
Use of iron-related pathways and genes for treatment and diagnosis of parkinson's disease
|
US20100008934A1
(en)
|
2008-07-02 |
2010-01-14 |
Celera Corporation |
Genetic polymorphisms associated with autoinflammatory diseases, methods of detection and uses thereof
|
MX2011002253A
(es)
|
2008-08-25 |
2011-03-29 |
Centocor Ortho Biotech Inc |
Biomarcadores para el tratamiento anti-factor de necrosis tumoral en la colitis ulcerativa y trastornos relacionados.
|
US20110136113A1
(en)
|
2008-08-27 |
2011-06-09 |
Sysmex Corporation |
Marker for detecting il-17-producing helper t cell, and method for detecting il-17-producing helper t cell
|
MX2011002153A
(es)
|
2008-08-28 |
2011-03-29 |
Wyeth Llc |
Usos de citocinas de las familias de interleucina-22, interleucina-17 e interleucina-1 en enfermedades autoinmunitarias.
|
JP2010088432A
(ja)
|
2008-09-09 |
2010-04-22 |
Kansetsu Saisei Kenkyusho:Kk |
Tnf阻害薬治療による有効性・副作用発現に関する多型、およびその利用
|
AU2009296299A1
(en)
|
2008-09-29 |
2010-04-01 |
Roche Glycart Ag |
Antibodies against human IL 17 and uses thereof
|
US8759035B2
(en)
|
2008-10-21 |
2014-06-24 |
Morehouse School Of Medicine |
Methods for determination of haplotype dissection
|
EP2359137A4
(en)
|
2008-11-11 |
2012-05-30 |
Prometheus Lab Inc |
METHOD FOR PREDICTING INFLAMMATORY ENDURANCE (IBD) DUE TO SEROLOGICAL MARKERS
|
US20110229471A1
(en)
|
2008-11-26 |
2011-09-22 |
Cedars-Sinai Medical Center |
Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
|
WO2010075579A2
(en)
|
2008-12-24 |
2010-07-01 |
Cedars-Sinai Medical Center |
Methods of predicting medically refractive ulcerative colitis (mr-uc) requiring colectomy
|
WO2010075584A1
(en)
|
2008-12-24 |
2010-07-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing and predicting crohns disease from childhood hygiene and serological profiles
|
US20170044615A1
(en)
|
2008-12-24 |
2017-02-16 |
Cedars-Sinai Medical Center |
METHODS OF PREDICTING MEDICALLY REFRACTIVE ULCERATIVE COLITIS (mrUC) REQUIRING COLECTOMY
|
WO2015168699A1
(en)
|
2014-05-02 |
2015-11-05 |
Cedars-Sinai Medical Center |
Methods of predicting medically refractive ulcerative colitis (mruc) requiring colectomy
|
US20120041082A1
(en)
|
2009-01-13 |
2012-02-16 |
Cedars-Sinai Medical Center |
Methods of using smad3 and jak2 genetic variants to diagnose and predict inflammatory bowel disease
|
EP2411412B1
(en)
|
2009-03-24 |
2015-05-27 |
Teva Biopharmaceuticals USA, Inc. |
Humanized antibodies against light and uses thereof
|
WO2010118210A1
(en)
|
2009-04-08 |
2010-10-14 |
Cedars-Sinai Medical Center |
Methods of predicting complication and surgery in crohn's disease
|
AU2010236568B2
(en)
|
2009-04-14 |
2015-08-27 |
Société des Produits Nestlé S.A. |
Inflammatory bowel disease prognostics
|
AU2010237046B2
(en)
|
2009-04-17 |
2015-06-04 |
New York University |
Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
|
JP2011004390A
(ja)
|
2009-05-18 |
2011-01-06 |
Canon Inc |
撮像装置、撮像システム、及び撮像装置の駆動方法
|
WO2010144358A1
(en)
|
2009-06-08 |
2010-12-16 |
Singulex, Inc. |
Highly sensitive biomarker panels
|
KR101807323B1
(ko)
|
2009-06-24 |
2017-12-08 |
큐알엔에이, 인크. |
Tnfr2에 대한 천연 안티센스 전사체의 억제에 의한 종양 괴사 인자 수용체 2(tnfr2) 관련된 질환의 치료
|
JP2012533322A
(ja)
|
2009-07-20 |
2012-12-27 |
ジェネンテック, インコーポレイテッド |
クローン病のための遺伝子発現マーカー
|
WO2011017120A1
(en)
|
2009-07-27 |
2011-02-10 |
Cedars-Sinai Medical Center |
Use of ccr9, ccl25, batf and il17/il23 pathway variants to diagnose and treat inflammatory bowel disease
|
KR20120089259A
(ko)
|
2009-08-03 |
2012-08-09 |
유니버시티 오브 마이애미 |
T 조절 세포의 생체 내 확장 방법
|
EP2509979B1
(en)
|
2009-12-07 |
2016-05-25 |
Boehringer Ingelheim International GmbH |
Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core
|
WO2011088306A1
(en)
|
2010-01-15 |
2011-07-21 |
Cedars-Sinai Medical Center |
Methods of using genetic variants to diagnose crohn's disease
|
WO2011106707A2
(en)
|
2010-02-26 |
2011-09-01 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to dr3
|
US20130012604A1
(en)
|
2010-03-16 |
2013-01-10 |
Cedars-Sinai Medical Center |
Methods of using prdm1 genetic variants to prognose, diagnose and treat inflammatory bowel disease
|
CA2805054A1
(en)
|
2010-08-25 |
2012-03-01 |
F. Hoffmann-La Roche Ag |
Antibodies against il-18r1 and uses thereof
|
PL2616489T3
(pl)
|
2010-09-16 |
2017-07-31 |
Baliopharm Ag |
Przeciwciało anty-huTNFR1
|
US8766034B2
(en)
|
2010-09-22 |
2014-07-01 |
Cedars-Sinai Medical Center |
TL1A model of inflammation fibrosis and autoimmunity
|
EP2630495B1
(en)
|
2010-10-18 |
2017-02-08 |
Nestec S.A. |
Methods for determining anti-drug antibody isotypes
|
JO3375B1
(ar)
|
2010-11-08 |
2019-03-13 |
Regeneron Pharma |
أجسام مضادة بشرية للجين a1 الشبيه بعامل النخر الورمي (tl1a)
|
WO2012071436A1
(en)
|
2010-11-24 |
2012-05-31 |
Genentech, Inc. |
Method of treating autoimmune inflammatory disorders using il-23r loss-of-function mutants
|
US9902996B2
(en)
|
2011-02-11 |
2018-02-27 |
Cedars-Sinai Medical Center |
Methods of predicting the need for surgery in crohn's disease
|
EP2676137B1
(en)
|
2011-02-17 |
2014-12-31 |
Nestec S.A. |
Assays for detecting autoantibodies to anti-tnf drugs
|
US20140018448A1
(en)
|
2011-03-25 |
2014-01-16 |
Cedars-Sinai Medical Center |
Role of ifng methylation in inflammatory bowel disease
|
CA2830362A1
(en)
|
2011-03-25 |
2012-10-04 |
Dermot P. Mcgovern |
Methods of diagnosing and treating intestinal granulomas and low bone density in inflammatory bowel disease
|
JP2014518883A
(ja)
|
2011-05-20 |
2014-08-07 |
ガバメント・オブ・ザ・ユナイテッド・ステイツ,アズ・リプリゼンテッド・バイ・ザ・セクレタリー,デパートメント・オブ・ヘルス・アンド・ヒューマン・サーヴィシズ |
T細胞媒介疾病の病態を改善させるためのtl1a−dr3相互作用の遮断及びその抗体
|
US8569462B2
(en)
*
|
2011-06-03 |
2013-10-29 |
Xoma Technology Ltd. |
Antibodies specific for TGF-beta and methods for treating thereof
|
US20140170157A1
(en)
|
2011-06-15 |
2014-06-19 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Method of selecting therapeutic indications
|
CN202109170U
(zh)
|
2011-06-21 |
2012-01-11 |
徐毓艺 |
多座旋转连接装置
|
US8478890B2
(en)
|
2011-07-15 |
2013-07-02 |
Damaka, Inc. |
System and method for reliable virtual bi-directional data stream communications with single socket point-to-multipoint capability
|
WO2013033627A2
(en)
|
2011-09-01 |
2013-03-07 |
The Regents Of The University Of California |
Diagnosis and treatment of arthritis using epigenetics
|
EP2565277A1
(en)
|
2011-09-05 |
2013-03-06 |
Progenika Biopharma, S.A. |
Method for predicting radiographic severity in ankylosing spondylitis
|
AU2012315474B2
(en)
*
|
2011-09-30 |
2017-10-26 |
Teva Pharmaceuticals Australia Pty Ltd. |
Antibodies against TL1a and uses thereof
|
CA2852954A1
(en)
|
2011-10-21 |
2013-04-25 |
Nestec S.A. |
Methods for improving inflammatory bowel disease diagnosis
|
US20130123117A1
(en)
|
2011-11-16 |
2013-05-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Capture probe and assay for analysis of fragmented nucleic acids
|
EA201491011A1
(ru)
|
2011-11-23 |
2014-09-30 |
Амген Инк. |
Способы лечения с помощью ингибитора гамма-интерферона
|
CA2922005A1
(en)
|
2012-09-27 |
2014-04-03 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
WO2014106602A1
(en)
|
2013-01-02 |
2014-07-10 |
Glenmark Pharmaceuticals S.A. |
Antibodies that bind to tl1a and their uses
|
CN103149371B
(zh)
|
2013-02-26 |
2015-12-23 |
哈药慈航制药股份有限公司 |
生物标记物在制备预测5-氨基水杨酸治疗溃疡性结肠炎的反馈响应药物中的应用
|
KR20220139415A
(ko)
|
2013-03-13 |
2022-10-14 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
선융합(prefusion) RSV F 단백질 및 이의 용도
|
MX2015013703A
(es)
|
2013-03-27 |
2016-08-11 |
Cedars Sinai Medical Center |
Mitigacion e inversion de la fibrosis e inflamacion mediante la inhibicion de la funcion de tl1a y vias de señalizacion relacionadas.
|
WO2014186665A2
(en)
|
2013-05-17 |
2014-11-20 |
Cedars-Sinai Medical Center |
Distinct effects of ifn-gamma and il-17 on tl1a modulated inflammation and fibrosis
|
KR102295125B1
(ko)
|
2013-05-17 |
2021-08-31 |
세다르스-신나이 메디칼 센터 |
크론병과 연관된 tnfsf15와 dcr3의 변이체
|
EP4105236A1
(en)
|
2013-07-19 |
2022-12-21 |
Cedars-Sinai Medical Center |
Anti-tl1a (tnfsf15) antibody for treatment of inflammatory bowel disease
|
WO2015035261A1
(en)
|
2013-09-06 |
2015-03-12 |
Cedars-Sinai Medical Center |
Systems, devices and methods for anti-tl1a therapy
|
HUE060420T2
(hu)
|
2013-09-13 |
2023-02-28 |
Beigene Switzerland Gmbh |
Anti-PD1 antitestek, valamint terapeutikumként és diagnosztikumként történõ alkalmazásuk
|
EP3068801A1
(en)
|
2013-11-13 |
2016-09-21 |
Pfizer Inc. |
Tumor necrosis factor-like ligand 1a specific antibodies and compositions and uses thereof
|
EP3137063A4
(en)
|
2014-05-02 |
2017-12-13 |
Teva Pharmaceutical Industries Ltd. |
Treatment of crohn's disease with delayed-release 6-mercaptopurine
|
US20150376612A1
(en)
|
2014-06-10 |
2015-12-31 |
The General Hospital Corporation |
CCCTC-Binding Factor (CTCF) RNA Interactome
|
CN113372434A
(zh)
|
2014-11-14 |
2021-09-10 |
豪夫迈·罗氏有限公司 |
包含tnf家族配体三聚体的抗原结合分子
|
CA2978616A1
(en)
|
2015-03-16 |
2016-09-22 |
Cedars-Sinai Medical Center |
Methods of treating inflammatory bowel disease with ifn-gamma therapy
|
WO2016170348A2
(en)
|
2015-04-22 |
2016-10-27 |
Mina Therapeutics Limited |
Sarna compositions and methods of use
|
US20180156781A1
(en)
|
2015-05-15 |
2018-06-07 |
Cedars-Sinai Medical Center |
Models, methods and compositions for treating inflammatory bowel disease
|
TWI703158B
(zh)
|
2015-09-18 |
2020-09-01 |
美商希佛隆公司 |
特異性結合tl1a之抗體
|
WO2017077715A1
(en)
|
2015-11-02 |
2017-05-11 |
La Jolla Institute For Allergy & Immunology |
Method and medicament for treating airway and/or lung diseases
|
CR20180365A
(es)
|
2015-12-16 |
2018-09-28 |
Amgen Inc |
PROTEÍNAS DE UNIÓN AL ANTÍGENO BISPECÍFICO DE ANTI-TL1A/ANTI-TNF-a Y SUS USOS
|
KR20220153109A
(ko)
|
2016-03-17 |
2022-11-17 |
세다르스-신나이 메디칼 센터 |
Rnaset2를 통한 염증성 장 질환의 진단 방법
|
KR102417687B1
(ko)
|
2016-05-09 |
2022-07-07 |
브리스톨-마이어스 스큅 컴퍼니 |
Tl1a 항체 및 그의 용도
|
WO2018022628A1
(en)
|
2016-07-25 |
2018-02-01 |
Cephalon, Inc. |
Affinity chromatography wash buffer
|
CN110121509A
(zh)
|
2016-10-26 |
2019-08-13 |
西达-赛奈医疗中心 |
中和抗tl1a单克隆抗体
|